Qiao Biao

Prof. Qiao Biao


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GCGuo Caizhen
Guo Caizhen
GYGao Yan
Gao Yan
CRChang Ronron
Chang Ronron
YLYang Lirong
Yang Lirong
CPChu Panpan
Chu Panpan
QLQingshan Li
Qingshan Li

23 September 2017 in Data in Brief
Verified
Journal Article
Open access
PDF file
QBQiao Biao
Qiao Biao
LSLi Song
Li Song
CZChenchen Zhu
Chenchen Zhu
QWQian Wang
Qian Wang
TGTianyan Guo
Tianyan Guo
QLQingshan Li
Qingshan Li
The data presented here are related to a research article entitled “Development of a phosphorylated Momordica charantia protein system for inhibiting susceptible dose-dependent C. albicans to available antimycotics: An allosteric regulation of protein” (Qiao et al., 2017) [1]. The data set includes three portions: (1) a relationship between reaction velocities of protein phosphorylation as a function of the substrate concentrations, determined in enzymatic reactions in aid of protein kinases; (2) a result of antifungal susceptibility testing of C. albicans after it is selected in antimycotics; and (3) a comparison of protein expression in the susceptible dose-dependent fungus relative to the wild C. albicans. In the first portion, the relationship of reaction velocities and substrate concentrations is expressed as an output from the inverse variation model. All data and analyses are made publicly available and citied in the research article using a style for the Data in Brief.

1 November 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
QBQiao Biao
Qiao Biao
LSLi Song
Li Song
CZChenchen Zhu
Chenchen Zhu
QWQian Wang
Qian Wang
TGTianyan Guo
Tianyan Guo
QLQingshan Li
Qingshan Li

5 September 2017 in Green Processing and Synthesis
Verified
Journal Article
Open access
PDF file
QBQiao Biao
Qiao Biao
WQWenhao Qin
Wenhao Qin
QLQingshan Li
Qingshan Li
A sealed wet curing design on sulfating Sorghum vinegar residue waste is drilled with sulfo/sulfoalkyl chemicals. Sulfation degrees in the case of reactions with sulfuric acid, sodium sulfite, sulfamic acid, benzenesulfonic acid, p -toluenesulfonic acid and sodium laurilsulfate range from 14.7 to 36.9 mg sulfo per gram waste. The C–O–S formation gives rise to accessional noncrystallinity and mesoporosity of morphology, a character for potential alternatives in catalysis. Waste sulfates are employed as candidates in catalyzing the condensation of α-glycolic acid and urea substitutes for yielding imidazolidine-2,4-dione derivatives. Catalytic and specific activities in terms of derivative productions are 2.6–34.3 (×10 3 U) and 0.8–5.4 U/mg sulfo, together with the maximal yields of 49.4%–97.6%. Chemical linkage of sulfo/sulfoalkyl groups manifests synergism with intrinsic acidity of waste with respect to catalysis. A rational design of green chemistry is guaranteed by no excess of chemicals and easy recyclability of catalysts.

1 September 2020 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
QBQiao Biao
Qiao Biao
ZLZhang Lan-Fang
Zhang Lan-Fang
QQQiao Qi
Qiao Qi
NJNiu Jia-Hui
Niu Jia-Hui
RZRen Ze-Mei
Ren Ze-Mei
QLQingshan Li
Qingshan Li
Fungal growth-dependent gene coregulation is strongly implicated in alteration of gene-encoding target proteases ruling with an antifungal resistance niche and biology of resistant mutants. On the basis of multi-alterative processes in this platform, the resistance-modifying strategy is designed in ketoconazole resistant Candida albicans and evaluated with less selective Momordica charantia protein and allosterically phosphorylated derivatives at the Thr102, Thr24 and Thr255 sites, respectively. We demonstrate absolutely chemo-sensitizing efficacy regarding stepwise-modifying resistance in sensitivity, by a load of only 26.23–40.00 μg/l agents in Sabouraud's dextrose broth. Five successive modifying-steps realize the decreasing of ketoconazole E-test MIC50 from 11.10 to a lower level than 0.10 mg/l. With the ketoconazole resistance-modifying, colony undergoes a high-frequency morphological switch between high ploidy (opaque) and small budding haploid (white). A cellular event in the first modifying-step associates with relatively slow exponential growth (ie, a 4-h delay)-dependent action, mediated by agents adsorption. Moreover, multiple molecular roles are coupled with intracellularly and extracellularly binding to ATP-dependent RNA helicase dbp6; the 0.08–2.45 fold upregulation of TATA-box-binding protein, rRNA-processing protein and translation initiation factor 5A; and the 7.52–55.33% decrease of cytochrome P450 lanosterol 14α-demethylase, glucan 1, 3-β glucosidase, candidapepsin-1 and 1-acylglycerol-3-phosphate O-acyltransferase. Spatial and temporal gene coregulation, in the transcription and translation initiation stages with rRNA-processing, is a new coprocessing platform enabling target protease attenuations for resistance-impairing. An updated resistance-modifying measure of these agents in the low-dose antifungal strategic design may provide opportunities to a virtually safe therapy that is in high dose-dependency. A new platform to modify resistance is fungal growth-dependent gene coregulation. MAP30 and phosphorylated derivatives are candidate resistance-modifying agents. Low-dose stepwise treatment absolutely modifies azole resistance in model fungus.

29 July 2020 in Research Square
Verified
Preprint
Open access
PDF file
LZLanfang Zhang
Lanfang Zhang
XZXiaoyan Zhang
Xiaoyan Zhang
LWLiying Wang
Liying Wang
WYWanxia Yang
Wanxia Yang
QBQiao Biao
Qiao Biao
QLQingshan Li
Qingshan Li
Background: Interleukin-6 (IL-6), an inflammatory cytokine, plays a majoy role in the pathogenesis of inflammation and serves as a key marker in the diagnosis and treatment of inflammation and related diseases. Formononetin (FMN), an isoflavone ingredient in various Chinese herbal medicines, inhibits the production of IL-6 in some cells. However, its mechanism of action has not been clearly established. In this study, we aimed to identify whether FMN inhibits IL-6 production in Lipopolysaccharide (LPS)-stimulated macrophages via AMPK activation.Methods: In the current study, the anti-IL-6 mechanism of FMN was evaluated using a macrophage model with LPS stimulation. An inverted microscope was utilized to obtain images of cells. Nuclear staining assay and CCK-8 assay were used to identify the viability of ANA-1 cells. The expression of IL-6 in cells was investigated by Enzyme-linked immunosorbent (ELISA) and Western blotting. The expression of AMP-activated protein kinase (AMPK) was determined by Western blotting and phosphorylation of AMPK was determined by Western blotting and Immunofluorescence assay. Bioinformatic analysis was used to predict potential targets of FMN. Results: we found that FMN reduced the expression of IL-6 in ANA-1 cells and increased the phosphorylation of AMPK. The effect of FMN was similar to that of acadesine, an AMPK activator, which also reduced IL-6 expression in LPS-induced ANA-1 cells and increased AMPK phosphorylation. Its combination with dorsomorphin (an AMPK inhibitor), however, reversed the effects of FMN on AMPK phosphorylation and IL-6 expression. The target of FMN was identified as the cAMP-dependent protein kinase inhibitor alpha, as searched in Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and further verified with the STRING database. Conclusions: In conclusion, our findings suggest that FMN effectively inhibits IL-6 production by activating AMPK in LPS-stimulated macrophages.